ScholarLens Back to search
2007•Zhongguo yaofangRequires access

Observation of Curative Effect of Montelukast on Children with CVA

Jian Chen

Open publisher page 0 citations

Abstract

OBJECTIVE:To investigate the curative effect of montelukast on children with CVA.METHDOS:The treatment group(n=42)was treated with bricany and montelukast.The control group(n=36)was treated with bricany and ketotifen.Bricany was with drawn until the symptom disappeared,then montelukast and ketotifen were still taken till the course of treatment reached 12 weeks.The recurrence rate was observed at the follow-up of 9 months. RESULTS:The remission time of two groups were(5.3±3.7)and(6.9±3.4)days in acute patient,respectively.The differences were not significant(P0.05).The recurrence rate(19.04%)and incidence of CVA(11.90%)of treatment group were significantly shorter(P0.05)than the control group(41.67% and 33.33%,respectively).CONCLUSION: Montelukast can control cough and the curative effect of it was significant,with lower recurrence rate and incidence of CVA.

About this research paper

What this paper is about

OBJECTIVE:To investigate the curative effect of montelukast on children with CVA.METHDOS:The treatment group(n=42)was treated with bricany and montelukast.The control group(n=36)was treated with bricany and ketotifen.Bricany was with drawn until the symptom disappeared,then montelukast and ketotifen were still taken till the course of treatment reached 12 weeks.The recurrence rate was observed at the follow-up of 9 months. RESULTS:The remission time of two groups were(5.3±3.7)and(6.9±3.4)days in acute patient,respectively.The differences were not significant(P0.05).The recurrence rate(19.04%)and incidence of CVA(11.90%)of treatment group were significantly shorter(P0.05)than the control group(41.67% and 33.33%,respectively).CONCLUSION: Montelukast can control cough and the curative effect of it was significant,with lower recurrence rate and incidence of CVA.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To investigate the curative effect of montelukast on children with CVA.METHDOS:The treatment group(n=42)was treated with bricany and montelukast.The control group(n=36)was treated with bricany and ketotifen.Bricany was with drawn until the symptom disappeared,then montelukast and ketotifen were still taken till the course of treatment reached 12 weeks.The recurrence rate was observed at the follow-up of 9 months. RESULTS:The remission time of two groups were(5.3±3.7)and(6.9±3.4)days in acute patient,respectively.The differences were not significant(P0.05).The recurrence rate(19.04%)and incidence of CVA(11.90%)of treatment group were significantly shorter(P0.05)than the control group(41.67% and 33.33%,respectively).CONCLUSION: Montelukast can control cough and the curative effect of it was significant,with lower recurrence rate and incidence of CVA.

Key concepts: Montelukast, Ketotifen, Medicine, Incidence (geometry), Anesthesia, Cure rate, Gastroenterology, Surgery

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Observation of Curative Effect of Montelukast on Children with CVA — Research Paper | ScholarLens